September 9, 2010
| eCliniqua > Advertise



Industry Trends

Loading...

Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials

By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore.  Read More



Advertise

Loading...

Reach key decision makers in profitable new markets. The Cambridge Healthtech Media Group provides access to a core audience from pharma, biotech, CROs, academia, technology, and niche service providers. Our consultative approach will help you create a comprehensive, multi-media package — targeting specific demographics — and incorporating your message within the published resources that our audiences trust.

For information on our lead generating podcasts, webcasts, white papers along with online and eNewsletter advertising options and more, please download the 2010 Cambridge Healthtech Media Kit (including the Editorial Calendar) here.

For immediate assistance, or specific questions, you may always contact Lynn Cloonan.

"Bio-IT World promised us hundreds of leads when we signed up for their white paper marketing program. And they delivered. They have obviously put a lot of time and thought into how to use the web as an effective lead generation tool.”
James Nichols, VP, Product Strategy & Marketing, Thomson Scientific

"Infotrieve’s first experience with Bio-IT World’s lead generation programs was through their custom produced webcast offering. Our encounter with this was so successful that we opted to follow up with their white paper lead generation program, which was another winner. Our sales team received many quality leads from qualified prospects looking to improve productivity using effective scientific software solutions.”
Ian Palmer, Director of Marketing, Infotrieve, Inc.


White Papers & Special Reports

sas_f0910
Rethinking Clinical Trials Data Integration
Sponsored by SAS

There is a gap between the need for data integration and fully integrated systems. To find out why, SAS and Pharmaceutical Executive conducted confidential telephone interviews with senior pharmaceutical executives and CROs. This article discusses recommendations on how to achieve optimal clinical data integration, based on those interviews.



ClearTrial_BriefingOn
eClinical Trial Technologies Revolutionizing Clinical Development Efficiency
Sponsored by ClearTrial
This Bio-IT World BriefingON report, sponsored by ClearTrial, presents a selection of recent stories from Bio•IT World and sister publication, eCliniqua, that illustrate how new technologies and approaches can have a profound impact on the management and execution of clinical trials.


oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



Life Science Webcasts & Podcasts

Bio-IT World & CHI

Impact of the 1000 Genomes Project on the Next Wave of Pharmacogenomic Discovery
1000genomeInterview with M. Eileen Dolan, Ph.D., Professor, Medicine, University of Chicago and Speaker at Next-Generation Sequencing Data Management, September 27-29, 2010, Providence, RI  

The 1000 Genomes Project aims to provide detailed genetic variation data on >1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International Hap-Map samples that are composed of lymphoblastoid cell lines (LCLs) derived from individuals of different world populations. The detailed map of human genetic variation promised by the 1000 Genomes project will allow a more in-depth analysis of the contribution of genetic variation to drug response. Future studies utilizing this new resource can greatly enhance our understanding of the genetic basis of drug response and other complex traits.


Download Now 



More Podcasts

Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.




Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.